La Traviata Royal Opera House, London Until March 23 Rating: Richard Eyre’s take on La Traviata celebrates its 25th birthday with performances through until late March, … Read more
Bring in the new year with uplifting fizz By Olly Smith Event for The Mail on Sunday Published: 22:02 GMT, 28 December 2019 | Updated: 22:02 GMT, 28 December 2019 Where has this year gone? It’s as pointless as asking why the sky is up. Much better to ponder what to drink on New Year’s … Read more
New tariffs on wine exported from Europe to the United States are being threatened by President Trump in the New Year – with fears of the tax being as high as 100 per cent. Yet despite concerns over the impact such a move could have on wine prices, there are still plenty of opportunities for those … Read more
George Kruis wins the ball in the lineout during the Rugby World Cup 2019 England rugby player George Kruis used cannabis oil during the World Cup to help him sleep better. He also says the best money decision he ever made was setting up a cannabis oil company to provide him with an income in … Read more
JEFF PRESTRIDGE: Raising money for charity Jeff Prestridge is planning to do the Royal Parks half-marathon on behalf of Prostate Cancer UK in 2020. He was diagnosed with the cancer earlier this year I have been quite impressed with myself this year on the raising money for charity front (my New Year’s resolution for 2019). … Read more
Woodford debacle shows the Financial Conduct Authority is STILL failing By Jeff Prestridge for The Mail on Sunday Published: 22:01 GMT, 28 December 2019 | Updated: 22:01 GMT, 28 December 2019 Over the years, I’ve learnt to look forwards, not backwards. To try to not regret personal mistakes made – and by Jove I’ve made … Read more
JEFF PRESTRIDGE: Could latest investment star Nick Train’s runaway funds hit the buffers? By Jeff Prestridge for The Mail on Sunday Published: 22:01 GMT, 28 December 2019 | Updated: 22:01 GMT, 28 December 2019 Nick Train has had two of his company’s five funds downgraded by scrutineer Morningstar Nick Train is the latest ‘star’ investment … Read more
What a momentous year 2019 has been! Almost the entire year was dominated by incessant wrangling over Brexit. Politicians prevaricated and the country suffered. The uncertainty lifted just in time to give markets a pre-Christmas boost. The road ahead may be tough but, at least with Boris Johnson, there is a determined driver at the wheel. … Read more
MIDAS SHARE TIPS: What a lifesaver! Health tester Renalytix gives investors a 50% boost By Joanne Hart for The Mail on Sunday Published: 22:01 GMT, 28 December 2019 | Updated: 22:01 GMT, 28 December 2019 Tips for the year apart, one of our top performers of 2019 was healthcare company Renalytix. The shares were recommended … Read more
CASH IN THE ATTIC: Why your old Subbuteo set could sell for thousands By Toby Walne for The Mail on Sunday Published: 22:00 GMT, 28 December 2019 | Updated: 22:00 GMT, 28 December 2019 Subbuteo sets with all the parts from the 1960s and 1970s are highly collectable Every week we give the low-down on … Read more
easyJet’s chief executive Johan Lundgren insists package holidays are here to stay Me second favourite airline?’ Johan Lundgren, the chief executive of budget European travel firm easyJet, is momentarily lost for words. ‘No, don’t worry,’ he says batting away the concerns of a PR adviser who suggests he might opt for a long-haul operator rather … Read more
Itsu, the Asian-inspired fast-food chain, will more than double in size over the next five years by opening 100 outlets across the UK and abroad, The Mail on Sunday can reveal. The ambitious expansion strategy, led by millionaire founder Julian Metcalfe, should treble Itsu’s sales – while other restaurants are struggling to survive. Half the … Read more
Thousands of Britons battling incurable blood cancer could be thrown a lifeline thanks to a new ‘two-pronged-attack’ combination drug therapy. Until now, patients with chronic lymphocytic leukaemia – also known as CLL, one of the most common types of blood cancer in adults – had to endure repeated rounds of gruelling chemotherapy to keep their … Read more